Pharmaceutical industry
Eli Lilly and Company, a global leader in pharmaceutical research, development, and manufacturing, has partnered with Spotfire, Inc. to implement a decision analytics infrastructure at its research and development sites in the United States and Europe. Lilly will leverage Spotfire's entire suite of Spotfire.net solutions to enable
Drugs
A federal appeals court ruling cleared the way for the sale of a generic version of Prozac, the world's top-selling antidepressant, as early as next summer. The ruling, which was in favor of Barr Laboratories, the company that will sell the first generic version of Prozac, is expected
Drugs
Andrx, a specialty pharmaceutical maker, faces a patent infringement suit from Abbott Labs over its proposed generic version of the anti-epilepsy drug Depakote. Abbott claims that Andrx's proposed generic version violates their patent rights, which were issued in 1991 and 1993. The dispute highlights the common practice of
Pharmaceutical industry
The loss of patent protection for Prozac has significant implications beyond the revenue loss for Eli Lilly, highlighting a shift in the pharmaceutical industry's dynamics from protectionism to partnership. As generics companies become increasingly sophisticated in navigating patent laws, the industry is witnessing a move away from legal
Pharmaceutical industry
Eli Lilly and Company, a leading innovation-driven corporation, faces a financial impact due to the court's ruling on the company's Prozac patent. The Court of Appeals for the Federal Circuit upheld the 2001 patent but invalidated the 2003 patent, leading the company to issue guidance on
Pharmaceutical industry
Federal regulators have approved Prozac, a medication used to control mood swings and discomfort in severe premenstrual syndrome (PMS). The U.S. Food & Drug Administration (FDA) has approved a new brand name, Sarafem, for the drug, which will be available in pharmacies in August. This approval marks the first
Drugs
Incyte Genomics and Eli Lilly have expanded their collaboration to accelerate the development of therapeutic proteins. The two companies will focus on the identification and selection of secreted molecules that are strong candidates for therapeutic protein development. Lilly will also obtain options to license multiple therapeutic protein patents from Incyte.
Pharmaceutical industry
Lilly Industries, a leading manufacturer of industrial coatings and specialty chemical products, has achieved record quarterly sales of $176.4 million for the second quarter ended May 31, 2000, representing a 3% increase over the same period last year. The company's net income for the quarter was $9.
Drugs
Donald W. Grimm, a veteran executive from the pharmaceutical, biotechnology, and medical device industries, has joined Qualigen's Board of Directors. With a distinguished career spanning over three decades, Grimm brings a wealth of expertise to the company. His most notable achievements include leading Hybritech, Inc. to a significant
Pharmaceutical industry
Valspar Corp.'s $975 million acquisition of Lilly Industries marks the Minneapolis-based company's 16th purchase in five years, expanding its industrial coatings product line and international reach. The deal is expected to save costs through raw material purchasing and reduce competition in the paint and coatings industry.
Drugs
Hire.com's e-Recruiter, a pioneering online recruitment solution, has been adopted by four major healthcare companies - Johnson & Johnson, US Oncology, Eli Lilly, and McKessonHBOC. This strategic partnership marks a significant milestone in Hire.com's growth as a provider of online recruiting expertise to companies
Drugs
Lilly Software Associates, a leading provider of supply chain solutions, has formed a reselling partnership with Loftware, Inc. to offer a complete barcode label design and printing capability to its customers. This partnership is expected to enhance VISUAL users' ability to gain a competitive advantage by providing a one-stop
